Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sichuan Kelun Botai Biomedical

Request full access
Chengdu, ChinaFounded 2016Biotech & Life Sciences

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
10.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Became $1B as Subsidiary, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Jul 2023 $164M $1.6B Undisclosed ↗
SERIES BOther financing Dec 2022 $200M $1.5B IDG Capital · Guanghua sycamore · China Cinda Asset Management · Sherpa Venture Partners ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
SecondWave SystemsDeveloping a novel, ultrasound-based wearable neuromodulation platform Minneapolis, United States Operational 19 $17M $28M
FunPepFunPep is an Industry-university collaboration bioventure company Ibaraki, Japan Operational
Arterial Health InternationalProvides clinical diagnostic tests for a comprehensive evaluation of cardiovascular disease risk factors Atlanta, United States Operational
LysoclearPremium laboratory research services for biotechnology and pharmaceutical companies, specializing in ocular toxicology and structural biology Lafayette, United States Operational
TAGCyx BiotechnologiesCreating candidate compounds for high-performance nucleic acid drugs with high affinity and specificity for target molecules using our proprietary nucleic acid basic technology Tokyo, Japan Acquired
Amygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction Palo Alto, United States Operational
AnHeart TherapeuticsPrecision medicine biopharmaceutical company leveraging expertise in clinical research and development and product registration focusing initially on oncology products Huangpu, China Acquired
Contraria BiotechDevelops innovative, cost-effective therapeutic and prophylactic drugs to combat global health challenges like antibiotic resistance, emerging diseases, and pandemics Siena, Italy Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sichuan Kelun Botai Biomedical in the Chengdu ecosystem

Live from Dealroom

The Sichuan Kelun Botai Biomedical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • IDG Capital
  • Guanghua sycamore
  • China Cinda Asset Management
  • Sherpa Venture Partners
  • SDIC Fund Management
  • MSD China
  • Ginkgo biloba
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Chengdu HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sichuan Kelun Botai Biomedical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sichuan Kelun Botai Biomedical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.